# 项目任务执行

**User:**   
**Created:** 4/22/2026 10:45:50  
**Updated:** 4/22/2026 11:12:21  
**Exported:** 4/22/2026 11:14:15  
**Link:** [https://chatgpt.com/c/69e8365c-e374-8322-a4d2-985f8b49fbfa](https://chatgpt.com/c/69e8365c-e374-8322-a4d2-985f8b49fbfa)  

## Prompt:
2026/4/22 10:45:46

chatgpt\_consultation\_prompt(1).md

File

请依照我上传给你的prompt，为我的项目cpet-safety-line-stage1 ，进行prompt中所述任务。

## Response:
2026/4/22 10:45:51

我先按你上传的说明，把仓库里的核心文档和实现文件读一遍，再结合近年的 CPET 与方法学文献，给你做一次系统性的“方法学体检”。同时我会重点盯住你提示的五个根本问题，尤其是 P1 循环依赖和 Stage I 的正确定位。

我还确认到一个更上游的不一致：仓库并不是只有一个“安全区”定义，而是规则标签、R/T/I 连续评分和 Phase G 结果锚定三套口径并存。下一步我会把论文叙事、配置和代码逐一对齐，判断应收敛到哪一个主定义。

更进一步看，Stage I 最站得住脚的产出可能不是“做出可部署预测器”，而是把汇总级 CPET 在哪里失效、为何失效、以及下一步缺什么数据讲清楚。与此同时，`zone_engine_v2` 的文档叙述与最终实现存在漂移，最好在论文和仓库里一并修正。

> **Accessing GitHub repo content for analysis**
>
> I need to help gather content from the GitHub repo, like documents and code files. I'll explore using the web to access the raw versions of the files (e.g., PLANNING.md, CLAUDE.md), checking if I can download or open them directly. I’m just wondering whether I should use a container for this download or not.
>
> **Clarifying steps for obtaining files and citations**
>
> I think I don’t need to ask for clarification, since the user was specific in their request. I’ll need to cite the uploaded file properly, possibly through the use of a special citation method, and make sure I mention it in the final response. For the repo files, I may try using GitHub and look into specific connectors for access.
>
> **Gathering recent literature and repository information**
>
> I’ll need to search the web for recent literature (2020 onwards), as the user requested, using official sources like papers and guidelines. Since I might need repo details, I’ll also try to find relevant files from GitHub. I'll ensure that all factual statements have proper citations, especially for web-derived info.
>
> **Searching repo content and considering GitHub access**
>
> I think the most straightforward way to explore the repo content might be through GitHub's raw URLs, which I can open. If I search for the relevant files, I can easily inspect them. I’ll go ahead and look for the right information now. Let’s try searching.
>
> **Searching GitHub repo for relevant project files**
>
> [joshua-9402/cpet-140-final-project - GitHub](https://github.com/joshua-9402/cpet-140-final-project)
> [Cardiopulmonary Exercise Testing: Methodology, Interpretation, and Role ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC11770537/)
> [Connected Papers | Find and explore academic papers](https://www.connectedpapers.com/)
> [GitHub Docs](https://docs.github.com/en)
> [How to write a great agents.md: Lessons from over 2,500 repositories](https://github.blog/ai-and-ml/github-copilot/how-to-write-a-great-agents-md-lessons-from-over-2500-repositories/)
> [Wk2_Submission.ipynb · GitHub](https://gist.github.com/patternproject/c8e973abeebc9238cdedae219168bfdd)
>
> **Accessing GitHub repo via raw URL**
>
> The search didn’t turn up the exact repo, possibly due to search indexing issues. I’ll try opening the repo’s main page directly through its raw URL — that might work! Let me try that and see if I can get access to the content.
>
> **Attempting direct URL access to repository**
>
> [GitHub - mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1)
>
> **Opening GitHub raw file via URL**
>
> I think using the GitHub raw URL directly might be the easiest way to access the necessary files. Since the repository is available through web access, I’ll try opening specific raw files with the `raw.githubusercontent.com` URL and see if it renders the required content
>
> **Exploring raw GitHub URLs with open tool**
>
> [raw.githubusercontent.com](https://raw.githubusercontent.com/mrxachen/cpet-safety-line-stage1/main/docs/PLANNING.md)
>
> **Accessing repo content for easier inspection**
>
> The raw plain text from the repo is interesting, but the lines are quite long without line breaks. It might be hard to navigate. Maybe using line numbers would help, but it might not be necessary. Since the repo is public, I’ll try cloning it via a container to inspect it more easily. Let’s try that.
>
> **Cloning repository for inspection**
>
>
> **Testing raw URL download for repo files**
>
> Since there's no internet access in the container, I need to use either web tools or container download for raw URLs. It might be easier to use container.download for raw files, since the network works there. I’ll give that a try to see if it works better.
>
> **Fetching core files for inspection**
>
> I can download the raw files individually and inspect them directly within the container. There's no need for PDF reading skills, and using the container for code execution should be fine. It's also good to compare with the uploaded prompt file, but it might not be required. Time to fetch the list of core files.
>
> **Downloading core files from repository**
>
>
> **Downloading files individually via container**
>
> I can use the container.download to fetch each file, but it seems I can only download one at a time. It's a bit slower but manageable, as there are only around 10 files to download. I’ll proceed with each download separately and make sure we get all the needed ones.
>
> **Downloading remaining files**
>
> I still need to download the rest of the files. It's a bit of a process, but we're almost there. Let's continue fetching them so everything gets covered, one file at a time. We'll wrap up once everything's downloaded and ready for inspection.
>
> **Trying multiple raw URLs**
>
> It looks like "container.download" worked before without being viewed, possibly because the raw URL was already in the conversation. Now it seems blocked. A solution could be to open each raw URL with web first, then go back to downloading with the container. I’ll try opening a few URLs.
>
> **Exploring methods to open and download raw URLs**
>
> [raw.githubusercontent.com](https://raw.githubusercontent.com/mrxachen/cpet-safety-line-stage1/main/paper/main_cn.tex)
>
> **Downloading files now that they're open**
>
> Now that I've opened the files, it's time to go ahead and download them. I'll start the process to make sure everything goes smoothly and the files are saved properly. This should work fine since we've sorted through the opening issue. Let's get them downloaded!
>
> **Downloading remaining files**
>
> I still need to download the remaining files that are open. Now, it's just a matter of finishing this last step. Once those are downloaded, everything should be good to go. Let's wrap it up and make sure all the files are securely downloaded!
>
> **Considering README download**
>
> I’m wondering if I should download the README file as well. It might not be necessary since we already have the planning document, but it's saved in a different directory. I think it would make sense to either move it or redownload it to a consistent directory for easier access.
>
> **Moving planning file to consistent directory**
>
>
> **Inspecting CLAUDE file content**
>
>
> **Inspecting planning document**
>
> I need to take a closer look at the planning document, particularly around some key lines. I’ll probably use a tool like `grep` to search for headings, so I can quickly pinpoint specific sections or important details. That should help keep things focused and efficient!
>
> **Inspecting key lines in planning document**
>
>
> **Inspecting key sections**
>
> I need to carefully examine the sections related to methodology principles, Phase G, and the current findings. These seem to contain important information, and I want to make sure I don't miss any details that could be crucial for the user’s objective or the task I'm working on.
>
> **Inspecting methodology principles and current findings**
>
>
> **Inspecting Phase G findings**
>
> I need to focus on reviewing the findings from Phase G. These might hold important insights or conclusions that could impact the overall understanding of the project or task I'm working on. It's essential to ensure nothing significant is missed here while analyzing the results.
>
> **Inspecting phase G findings**
>
>
> **Reviewing DEVLOG for Phase G results**
>
> I need to check the DEVLOG to get the most current results after Phase G. It’s possible there are updates or clarifications in the log. I'll look for specific headings and use a search method to filter out the relevant sections for easier review.
>
> **Extracting DEVLOG entries with headings**
>
>
> **Reviewing sessions #18 and #19**
>
> I need to take a closer look at sessions #18 and #19 to gather relevant insights. It’s important to review both of these as they might contain data or outcomes that I can reference. I'll inspect them to see the key details and ensure I haven't missed anything important.
>
> **Inspecting session #18 and #19 logs**
>
>
> **Reviewing session #17 for methodology details**
>
> I’m considering pulling more information from session #17 to help with the methodology details. I’m also thinking of labeling it as v3, but I’m not totally sure if I’ll need that extra step. I’ll review what’s helpful and make adjustments once I’ve gone through it.
>
> **Extracting session #17 methodology details**
>
>
> **Reviewing session #15 for critical findings**
>
> I think it would be useful to examine session #15 a bit more carefully, as there might be some important insights or critical findings that I overlooked. It could also contain some relevant points raised by the reviewer that I should address, so I’ll make sure to go through it thoroughly.
>
> **Inspecting critical findings in session #15**
>
>
> **Reviewing key components using sed/grep**
>
> I need to inspect the label rules for v2 and v3, along with the leakage_guard and zone_engine_v2. I'll use sed and grep to filter out the relevant details from the data. These may help in ensuring accuracy and preventing unintended issues, so it's important I review this carefully.
>
> **Inspecting label_rules_v2 content**
>
>
> **Checking leakage guard in v2**
>
> I should continue reviewing version 2, especially focusing on any lines related to the leakage guard. These are critical for ensuring there are no unintended issues. I’ll need to make sure the implementation aligns with our expectations and thoroughly inspect any related code before moving forward.
>
> **Extracting specific lines from YAML file**
>
>
> **Moving forward with v3**
>
> I need to focus on version 3 now. It seems like the next step in the process. I'll need to ensure I understand the requirements and how it builds upon previous versions. Once I explore it, I can figure out the next actions needed.
>
> **Extracting first 260 lines from v3 file**
>
>
> **Focusing on leakage_guard**
>
> I need to pay attention to the leakage_guard. This seems important for ensuring that data or information is properly secured or protected. I'll consider how it fits into the overall process and make sure that I'm addressing it appropriately before moving on with the next steps.
>
> **Extracting leakage guard code snippet**
>
>
> **Looking for zone_engine_v2 sections**
>
> I need to find the relevant sections for zone_engine_v2. I'll look for any headings and comments within the documentation to better understand where the important parts are. This should guide me to the sections I need. I'll focus on those for the next steps.
>
> **Searching relevant sections in zone_engine_v2**
>
>
> **Inspecting the top docstring and scoring methods**
>
> I need to take a closer look at the top docstring and the methods related to scoring definitions in the code. I’ll also pay attention to how equal weights are handled, as this could be central to understanding the logic. Focusing on these key areas should yield the necessary insights.
>
> **Inspecting docstring and scoring methods**
>
>
> **Looking into the build method**
>
> I need to examine the relevant build method, especially how it handles equal weights. This might provide important context for understanding how the system operates when these weights are applied. I should focus on this section to clarify how it impacts the overall functionality.
>
> **Extracting code snippet from file**
>
>
> **Continuing with the cutpoints process**
>
> I should continue looking into cutpoints and related aspects. These will likely play a key role in further refining the process. I'll need to examine how they fit into the larger picture and ensure the implementation aligns with the desired outcome.
>
> **Extracting specific lines from file**
>
>
> **Inspecting tex files for relevant content**
>
> I should dive deeper into the supplementary and main tex files, especially focusing on the results and discussion sections. These areas should directly address the questions. I'll search for relevant metrics using a grep command to quickly sift through and isolate the key information.
>
> **Searching for specific metrics in tex files**
>
>
> **Reviewing supplementary sections**
>
> I should take a closer look at the supplementary material, especially sections S2-S4 and S6-S8. These sections may hold key information that could address specific aspects I'm investigating. I'll focus on these areas to get a better sense of relevant details related to the user's request.
>
> **Inspecting supplementary sections S2-S4 and S6-S8**
>
>
> **Examining supplementary results**
>
> I need to continue reviewing the supplementary results to gather additional information. These might contain key insights that complement the main findings, possibly addressing specific details I need for the user's inquiry. I’ll focus on these to refine the answer.
>
> **Extracting supplementary results from document**
>
>
> **Reviewing main_cn discussion and limitations**
>
> I need to inspect the main section for the discussion and limitations, as they may include specific wording that could be helpful for the task. I’ll focus on searching through relevant headings and snippet lines around the discussion sections to gather the most pertinent information.
>
> **Searching section headings in main_cn.tex**
>
>
> **Inspecting results and discussion from 494 onwards**
>
> I need to focus on reviewing the results and discussion starting from line 494. By concentrating on this specific range, I can gather insights that might be crucial to answering the user’s query or clarifying any relevant points. I'll carefully go through this section.
>
> **Inspecting content from lines 494 to 590**
>
>
> **Planning a robust research approach for user’s request**
>
> I need to offer a deep critique of the methodology, suggest alternative methods, and recommend relevant literature. I'll focus on searching the latest 2020+ Chinese literature on CPET, Chinese cardiovascular reference intervals, and machine learning in this field. I'll also explore trusted databases like PubMed for updated reports and guidelines.
>
> **Searching for up-to-date literature and key insights**
>
> I'll gather recent research from 2020 onward, focusing on topics like CPET reference intervals in Chinese cardiovascular patients, adverse event prediction, exercise intensity scoring methods, and best practices for using machine learning with small CPET datasets. I'll search for Chinese-specific guidelines and consensus-based literature, especially from 2022.
>
> **Searching recent Chinese CPET literature and guidelines**
>
> [Rehabilitation of Cardiovascular Diseases in China - PubMed](https://pubmed.ncbi.nlm.nih.gov/39734652/)
>
> **Refining literature search for China-specific CPET research**
>
> I'll refine the search for China-specific reference equations and CPET consensus, particularly for adult populations. PubMed is a good start, with articles like PMID 40157952 and 38488145. I'll also look for CVD rehab risk guidelines from Chinese consensus sources and check CNKI as well. This search may yield non-disease-specific data too, which is fine.
>
> **Searching for Chinese CPET reference standards and consensus**
>
> [A reference equation for peak oxygen uptake for cycle ergometry in ...](https://pubmed.ncbi.nlm.nih.gov/40157952/)
>
> **Exploring relevant literature for CPET and cardiovascular research**
>
> It looks like search results 958344search3, 958344search10, and 958344search7 may provide useful information on hypertensive patients, CHD prediction, and CPET-guided rehabilitation for older populations. I should explore these for more details, especially on 2025 trends. Also, I need to look further into HF prognostic multi-parameter scores like MECKI, CPX, and FRIEND.
>
> **Searching for heart failure prognostic score research**
>
>
> **Looking into Chinese hypertensive research for older adults**
>
> I think I need more detailed information on Chinese older hypertensives, so I’ll focus on search result 958344search3 and open it for further insights. This might provide the specific reference values I'm looking for to help with the user's query.
>
> **Searching for Chinese hypertensives paper and details**
>
> [Checking your browser - reCAPTCHA](https://pubmed.ncbi.nlm.nih.gov/36450553/)
>
> **Navigating search results for CPR and CPET literature**
>
> I’m considering whether I really need to actually open PubMed since it sometimes triggers captcha. The search result snippets might already give me usable info, like citations, and some abstracts could provide enough details. I might focus on using search results, PubMed’s PMC, or search by DOI for more specific papers. Also considering Chinese consensus guidelines for CPET safety. Let me figure out the best way to avoid issues with recaptcha.
>
> **Searching PubMed and PMCID for CPET reviews**
>
> [Cardiopulmonary Exercise Testing: Methodology, Interpretation, and Role ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC11770537/)
>
> **Searching for PROBAST-AI**
>
> I should look up PROBAST-AI. It sounds like an important search to better understand the guidelines for machine learning in clinical prediction, especially with the context I’m working on. Let’s find relevant papers or reviews to pull more data and clarify how it might apply here.
>
> **Searching for PROBAST-AI risk of bias studies**
>
> [Protocol for development of a reporting guideline (TRIPOD-AI) and risk ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC8273461/)
>
> **Searching for exercise prescription and CPET guidelines**
>
> I should look for reviews or guidelines that focus on exercise prescription using CPET, specifically to understand threshold zones rather than just safety zones. It would be useful to also explore how cardiac rehab integrates these principles. This could help clarify optimal thresholds for patient exercise.
>
> **Searching for CPET-based cardiac rehab exercise guidelines**
>
> [Exercise intensity domains determined by heart rate at the ventilatory ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC10391816/)
> [Cardiopulmonary Exercise Testing: Methodology, Interpretation, and Role ...](https://pubmed.ncbi.nlm.nih.gov/39872828/)
>
> **Searching for CPET score or HF prognosis details**
>
> I'll need to look up recent reviews or validations on CPET scoring systems or composite prognostic scores for heart failure (HF). Open access articles on PMC might provide the most relevant and up-to-date findings. This could help clarify the use of CPET values in HF prognosis.
>
> **Searching PMCs for CPET score reviews in heart failure**
>
> [Cardiopulmonary exercise testing criteria for advanced therapies in ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC11261342/)
>
> **Exploring potential critiques and issues in repo files**
>
> I’m reviewing the core evaluation method and considering potential alternative strategies. There seems to be a leakage guard for certain variables, but some issues arise with the structure, like how the I-axis uses internal weightings based on heuristics. T-axis exercise habit bonuses seem odd as well.
>
> **Examining exercise habit bonus and its potential issues**
>
> The exercise habit bonus adds +10, but if the data is self-reported, it could mix with physiological thresholds and skew the axis meaning. I should check where the `t3_exercise_habit_bonus` is computed from and whether it’s based on behavior, not CPET. I'll inspect further components like `_compute_r_axis_v2`.
>
> **Inspecting code for potential leakage and structural issues**
>
>
> **Inspecting axis computation formulas**
>
> I should take a closer look at how the axis computation formulas are defined to ensure everything is working as expected. It's important for understanding how different components like the exercise habit or physiological thresholds are impacting the final outputs. I’ll dive into these formulas now.
>
> **Inspecting axis computation formulas**
>
>
> **Checking reference subset and test result details**
>
> I find an interesting result where the tokens used show 0, which might be irrelevant. I should check the docs or DEVLOG for insights on the reference subset and zone distribution by cohort, but it might be enough already. Still, I need to search for "test_result" to see if it is a clinical outcome or composite interpretation.
>
> **Searching code for test_result references**
>
>
> **Checking binary outcome conversion and test result interpretation**
>
> I should look more closely at the lines for binary outcome conversion to understand how categories are defined. It might also be helpful to mention that if "test_result" isn’t a hard endpoint, it could be based on clinician interpretation or synthesis, which isn’t always straightforward.
>
> **Inspecting code for binary outcome conversion**
>
>
> **Inspecting reference percentile function**
>
> I should go over the reference percentiles function to understand how it's calculated. It might be important to understand its role in the system because it could affect how outcomes or scores are interpreted. This could help clarify how different criteria are weighted or applied.
>
> **Inspecting reference percentiles in code**
>
>
> **Considering citation strategy and source references**
>
> The system summary says tokens used are 0, which is fine. Now, I need to maybe inspect the planning, data snapshot, and methodology. The repository commit date might not be needed. I’ll fetch raw docs for citations, considering GitHub references. But we can’t cite from local containers; it must be from web or file search.
>
> **Addressing raw source and citation issues**
>
> The open page returned very long lines with large text. I may need to focus on specific line numbers to handle these properly. Raw plain text compresses lines, but citations can still be made. GitHub blobs could work better for line-level citations, as they support code lines.
>
> **Inspecting GitHub repository for citation and code details**
>
> [cpet-safety-line-stage1/configs/data/label_rules_v2.yaml at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/configs/data/label_rules_v2.yaml)
>
> **Focusing on relevant lines for code details**
>
> I need to open specific lines around label_rules_v2, v3, leakage_guard, and zone_engine_v2, especially near line 466. This approach will pinpoint the necessary sections for accurate citation and understanding of the code. I'll focus on reading and referencing those lines as needed.
>
> **Opening code around specific lines for labels and zones**
>
> [cpet-safety-line-stage1/configs/data/label_rules_v2.yaml at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/configs/data/label_rules_v2.yaml)
>
> **Expanding view on v3 zone_rules**
>
> I need to open additional lines specifically around the v3 zone_rules to get a more complete understanding of how they function. Focusing on these lines will help me pull the relevant details and ensure I’ve got the full context to cite them accurately.
>
> **Exploring open lines for v3 zone rules**
>
> [cpet-safety-line-stage1/configs/data/label_rules_v3.yaml at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/configs/data/label_rules_v3.yaml)
>
> **Looking into lines for T-axis bonus and equal weights**
>
> I need to locate the lines concerning the T-axis bonus and equal weights during the build process. These details are crucial to understand how things are balanced and to ensure the proper weights and bonuses are applied as expected in the model’s architecture.
>
> **Generating T-axis bonus and weight equalization lines**
>
> [cpet-safety-line-stage1/src/cpet_stage1/labels/zone_engine_v2.py at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/src/cpet_stage1/labels/zone_engine_v2.py)
>
> **Looking for more details on equal weights and ref cutpoints**
>
> I need to locate additional lines of code or configuration related to equal weights and reference cutpoints. These elements will help me understand how equal weightings are being applied and how the cutpoint references are being set up in the current build.
>
> **Clarifying equal weights and reference cutpoints**
>
> [cpet-safety-line-stage1/src/cpet_stage1/labels/zone_engine_v2.py at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/src/cpet_stage1/labels/zone_engine_v2.py)
>
> **Opening lines for leakage_guard and P1 exclusions**
>
> I need to check the lines surrounding the `leakage_guard` in relation to the P1 exclusions. Specifically, I’m looking for the relevant code or rules that handle how these exclusions are being processed within the `leakage_guard` section. This will help ensure consistency and accuracy.
>
> **Modifying leakage_guard lines for P1 exclusions**
>
> [cpet-safety-line-stage1/src/cpet_stage1/labels/leakage_guard.py at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/src/cpet_stage1/labels/leakage_guard.py)
>
> **Accessing v3 zone rules lines**
>
> I need to open the specific lines related to the v3 actual zone rules. It seems like using a search function (or "find") might help identify these lines quickly so I can review the details. This will help me pinpoint the exact parts I'm looking for more efficiently.
>
> **Finding Open V3 zone rules lines**
>
> [cpet-safety-line-stage1/configs/data/label_rules_v3.yaml at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/configs/data/label_rules_v3.yaml)
>
> **Opening planning details for Phase G and Stage I**
>
> I need to check the repository citations and focus on the planning around Phase G and Stage I positioning with appropriate line references. It might be best to open the `PLANNING.md` file on GitHub with line numbers included, since the raw file had too much detail in line 0. Let's do this.
>
> **Browsing GitHub for PLANNING.md with line numbers**
>
> [cpet-safety-line-stage1/docs/PLANNING.md at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/docs/PLANNING.md)
>
> **Finalizing citations and gathering sources for specifics**
>
> I need to ensure all factual claims are backed by citations, including the uploaded file and web sources. Since we've used the web once, all claims requiring support should be cited. I'll gather more precise citations for metrics from research papers and repo planning. Let's search and open specific pages with line numbers for clarity.
>
> **Gathering citations and metrics for factual claims**
>
> [cpet-safety-line-stage1/paper/main_cn.tex at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/main_cn.tex)
>
> **Gathering citations for P1 label definitions and leakage guard**
>
> I need to gather citations for P1 label definitions and leakage guard. Specifically, I'll use web finds to source information on `label_rules_v2` and `leakage_guard`. These sources will help back up the details I’m presenting, ensuring all claims are properly cited.
>
> **Searching for citations on P1 label and leakage guard**
>
> [cpet-safety-line-stage1/configs/data/label_rules_v2.yaml at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/configs/data/label_rules_v2.yaml)
>
> **Getting citations for equal weights and percentile cutpoints in zone_engine**
>
> I'll need citations for the equal weights and percentile cutpoints used in the `zone_engine`. It's important to get specific details to back up these claims, ensuring everything is well-supported. I'll look into where these concepts are defined or referenced clearly.
>
> **Searching for citations on zone_engine equal weights**
>
> [cpet-safety-line-stage1/src/cpet_stage1/labels/zone_engine_v2.py at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/src/cpet_stage1/labels/zone_engine_v2.py)
>
> **Looking for citations on planning stage aim and leakage constraint**
>
> I need citations for the planning stage aim, focusing on *not prediction*, and the strong leakage constraint. There might be enough information already on the website, so I'll inspect the lines around 250 to check the relevant references and ensure it's well-supported. Let's dive into that!
>
> **Inspecting surrounding lines for relevant citations and constraints**
>
> [cpet-safety-line-stage1/docs/PLANNING.md at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/docs/PLANNING.md)
>
> **Looking for citations on V3 and internal weights**
>
> I need citations to confirm if V3 is still using VO2/VE-VCO2 for learning true patterns, but we might be able to infer this. I'll mention V3 less if needed. Also, I need citations for hidden internal weights on the I axis, especially around the 0.30 value. Let's explore that.
>
> **Searching for citations on VO2/VE-VCO2 and weights**
>
> [cpet-safety-line-stage1/src/cpet_stage1/labels/zone_engine_v2.py at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/src/cpet_stage1/labels/zone_engine_v2.py)
>
> **Looking for more citations from search results**
>
> I need citations for the literature I’ve referenced. The search results might be enough, but opening a few key sources could strengthen the claims. I’ll inspect relevant search results, checking for specific details, exact lines, and word limits. We’ll need citations for CPX score and MECKI too. Let's open some sources.
>
> **Inspecting relevant search results and sources directly**
>
> [Checking your browser - reCAPTCHA](https://pubmed.ncbi.nlm.nih.gov/23392791/)
> [Checking your browser - reCAPTCHA](https://pmc.ncbi.nlm.nih.gov/articles/PMC7691632/)
>
> **Getting search result snippets for citations**
>
> It seems that recaptcha popped up, but the search results are still usable. I’ll need the search result snippets to cite, so I'll run searches again to get those visible in the current context. Alternatively, I could check the previous search results for available snippets and use those for citations.
>
> **Rerunning targeted searches for cardiopulmonary exercise test snippets**
>
> [Reference Standards of Cardiorespiratory Fitness Measured With the ...](https://pubmed.ncbi.nlm.nih.gov/38488145/)
> [A reference equation for peak oxygen uptake for cycle ergometry in ...](https://www.nature.com/articles/s41598-025-94207-7)
> [[Relationship between cardiopulmonary exercise testing and the ...](https://visualize.jove.com/39289994)
> [A meta-analysis of the prognostic significance of cardiopulmonary ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC7245616/)
> [Reference Standards of Cardiorespiratory Fitness Measured With the ...](https://scispace.com/papers/reference-standards-of-cardiorespiratory-fitness-measured-3a6wm3za54)
> [The association of coronary artery disease with heart rate at anaerobic ...](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1442857/pdf?isPublishedV2=false)
> [(1329) - Prognostic Significance of Cardiopulmonary Exercise Testing in ...](https://www.jhltonline.org/article/S1053-2498%2825%2901425-1/fulltext)
> [A reference equation for peak oxygen uptake for cycle ergometry in ...](https://www.x-mol.com/paper/1906024731727081472)
> [Respiratory gas kinetics in patients with congestive heart failure ...](https://www.sciencedirect.com/science/article/pii/S1807593223000613)
> [Reference Standards of Cardiorespiratory Fitness Measured With the ...](https://europepmc.org/article/MED/38488145)
> [A reference equation for peak oxygen uptake for cycle ergometry in ...](https://jglobal.jst.go.jp/en/detail?JGLOBAL_ID=202502223907320862)
> [Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients ...](https://clinicaltrials.gov/study/NCT07130968)
> [Cardiopulmonary Exercise Testing in the Prognostic Assessment of Heart ...](https://www.mdpi.com/1648-9144/61/10/1770)
> [Reference Standards of Cardiorespiratory Fitness Measured With the ...](https://ouci.dntb.gov.ua/en/works/ldGxgNk4/)
> [Oxygen Uptake Efficiency Slope and Prognosis in Heart Failure With ...](https://www.ajconline.org/article/S0002-9149%2823%2900390-9/fulltext)
> [Cardiopulmonary Exercise Testing (CPET) In Adults](https://www.physio-pedia.com/Cardiopulmonary_Exercise_Testing_%28CPET%29_In_Adults)
> [Heart Failure CPX Consortium - cardiology.org](https://cardiology.org/project/heart-failure-cpx-consortium/)
>
> **Searching for Chinese hypertension CPET reference values**
>
> I’m thinking of searching for older Chinese CPET reference values related to hypertension and exercise prescription guidelines. It would help provide a solid foundation for the task at hand. I'll look for relevant consensus papers, too, to gather a broader perspective on the subject.
>
> **Searching for Chinese hypertension CPET reference values and guidelines**
>
> [High Pulse Pressure Decreases Cardiopulmonary Ability among Older ...](https://pubmed.ncbi.nlm.nih.gov/36450553/)
> [Exercise intensity domains determined by heart rate at the ventilatory ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC10391816/)
> [A reference equation for peak oxygen uptake for cycle ergometry in ...](https://www.nature.com/articles/s41598-025-94207-7)
> [[Expert consensus on cardiovascular risk assessment and prevention in ...](https://www.scilit.com/publications/c2a30503a1a3efde0f18721862c3838c)
> [Do Clinical Exercise Tests Permit Exercise Threshold Identification in ...](https://www.sciencedirect.com/science/article/pii/S0828282X23015659)
> [High Pulse Pressure Decreases Cardiopulmonary Ability among Older ...](https://www.jstage.jst.go.jp/article/ihj/63/6/63_22-378/_pdf/-char/en)
> [心肺运动试验临床规范应用中国专家共识 - 中华心血管病杂志](https://rs.yiigle.com/cmaid/1430505)
> [A Clinical Guide for Assessment and Prescription of Exercise and ...](https://www.heartlungcirc.org/article/S1443-9506%2823%2904214-2/fulltext)
> [[Chinese expert consensus on standardized clinical application of ...](https://europepmc.org/article/MED/36299220)
> [Exercise intensity domains determined by heart rate at the ventilatory ...](https://bmjopensem.bmj.com/content/9/3/e001601)
> [Characteristics and reference values for cardiopulmonary exercise ...](https://www.researchgate.net/publication/350009880_Characteristics_and_reference_values_for_cardiopulmonary_exercise_testing_in_the_adult_Chinese_population_-_The_Xiangya_hospital_exercise_testing_project_the_X-ET_project/fulltext/609fbe4292851cfdf3338878/Characteristics-and-reference-values-for-cardiopulmonary-exercise-testing-in-the-adult-Chinese-population-The-Xiangya-hospital-exercise-testing-project-the-X-ET-project.pdf)
> [Cardiopulmonary exercise testing in cardiovascular disease](https://www.uptodate.com/contents/cardiopulmonary-exercise-testing-in-cardiovascular-disease)
> [Practical guide to cardiopulmonary exercise testing in adults](https://link.springer.com/content/pdf/10.1186/s12931-021-01895-6.pdf)
> [Exercise intensity domains determined by heart rate at ventilatory ...](https://academic.oup.com/eurheartj/article/43/Supplement_2/ehac544.2475/6745626)
> [Real-World Cohort Study of Cardiopulmonary Function in Chinese Patients ...](https://clinicaltrials.gov/study/NCT07130968)
> [Cardiopulmonary Exercise Testing - Clinics in Chest Medicine](https://www.chestmed.theclinics.com/article/S0272-5231%2825%2900035-8/fulltext)
> [Characteristics and reference values for cardiopulmonary exercise ...](https://read.qxmd.com/read/33716041/characteristics-and-reference-values-for-cardiopulmonary-exercise-testing-in-the-adult-chinese-population-the-xiangya-hospital-exercise-testing-project-the-x-et-project)
> [Characteristics and reference values for cardiopulmonary exercise ...](https://mayoclinic.elsevierpure.com/en/publications/characteristics-and-reference-values-for-cardiopulmonary-exercise/)
> [Login | Charles Schwab](https://client.schwab.com/Areas/Access/Login)
> [CPET and Exercise Prescription for Cardiac Rehabilitation | USC Journal](https://www.uscjournal.com/articles/cardiopulmonary-exercise-testing-methodology-interpretation-and-role-exercise-prescription?language_content_entity%3Den=)
> [Exercise intensity prescription in cardiovascular rehabilitation ...](https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1380639/full)
>
> **Looking for small data prediction model guidance**
>
> I should probably search for methodology guidance on creating prediction models, especially when dealing with small datasets and overfitting. It’s crucial to find reliable guidance on these topics. I’ll aim to grab relevant snippets from sources to get the most useful insights.
>
> **Searching for prediction model guidance and best practices**
>
> [TRIPOD+AI statement: updated guidance for reporting clinical prediction ...](https://www.bmj.com/content/385/bmj-2023-078378)
> [Empirical simulation of internal validation methods for prediction ...](https://www.sciencedirect.com/science/article/pii/S0895435625004342)
> [Estimation of minimal data sets sizes for machine learning predictions ...](https://www.nature.com/articles/s41746-024-01360-w)
> [TRIPOD+AI statement: updated guidance for reporting clinical prediction ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC11019967/)
> [Importance of sample size on the quality and utility of AI-based ...](https://www.thelancet.com/journals/landig/article/PIIS2589-7500%2825%2900021-4/fulltext)
> [TRIPOD+AI statement: updated guidance for reporting clinical prediction ...](https://www.equator-network.org/reporting-guidelines/tripod-statement/)
> [Tripod statement](https://www.tripod-statement.org/)
> [Empirical simulation of internal validation methods for prediction ...](https://www.jclinepi.com/article/S0895-4356%2825%2900434-2/fulltext)
> [Sample Size Calculations for Developing Clinical Prediction Models ...](https://arxiv.org/pdf/2602.23507)
> [TRIPOD+AI: Updated Reporting Guidelines for Clinical Prediction Models](https://healthpolicy.fsi.stanford.edu/news/tripodai-updated-reporting-guidelines-clinical-prediction-models)
> [Risk of bias in studies on prediction models developed using supervised ...](https://solo.bodleian.ox.ac.uk/discovery/fulldisplay/alma991025219182407026/44OXF_INST%3ASOLO)
> [Empirical evaluation of internal validation methods for prediction in ...](https://link.springer.com/article/10.1186/s12874-023-01844-5)
> [TRIPOD+AI statement: updated guidance for reporting clinical prediction ...](https://ora.ox.ac.uk/objects/uuid%3A414e5fb8-5575-4b67-b94d-a0833a7cc58a)
> [Dataset for systematic review on risk of bias of studies on prediction ...](https://www.dataverse.nl/dataset.xhtml?persistentId=doi%3A10.34894%2F5OEAMQ)
> [Empirical evaluation of internal validation methods for prediction in ...](https://www.researchgate.net/publication/367767788_Empirical_evaluation_of_internal_validation_methods_for_prediction_in_large-scale_clinical_data_with_rare-event_outcomes_a_case_study_in_suicide_risk_prediction/fulltext/63daa6e462d2a24f92e78f54/367767788_Empirical_evaluation_of_internal_validation_methods_for_prediction_in_large-scale_clinical_data_with_rare-event_outcomes_a_case_study_in_suicide_risk_prediction.pdf)
>
> **Searching for CPX score details**
>
> I should search for specifics about the CPX score, as the source I had previously is no longer visible. A targeted search should help me find additional reliable information, so I can get the details I need. Let’s focus on getting precise, relevant results.
>
> **Searching for CPX score and related metrics**
>
> [A meta-analysis of the prognostic significance of cardiopulmonary ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC7245616/)
> [International validation of the Metabolic Exercise test data combined ...](https://pubmed.ncbi.nlm.nih.gov/37288595/)
> [Predictive Value of Cardiopulmonary Exercise Testing Parameters in ...](https://www.sciencedirect.com/science/article/pii/S2213177920307034)
> [International Validation of Metabolic Exercise test data combined with ...](https://cpxinternational.com/pubs/international-validation-of-metabolic-exercise-test-data-combined-with-cardiac-and-kidney-indexes-mecki-score-in-heart-failure/)
> [Comprehensive Analysis of Cardiopulmonary Exercise Testing and ...](https://onlinejcf.com/article/S1071-9164%2815%2900176-1/fulltext)
> [International Validation of Metabolic Exercise test data combined with ...](https://www.lifescience.net/publications/343377/international-validation-of-metabolic-exercise-tes/)
> [A meta-analysis of the prognostic significance of cardiopulmonary ...](https://link.springer.com/article/10.1007/s10741-012-9332-0)
> [Heart Failure CPX Consortium - cardiology.org](https://cardiology.org/project/heart-failure-cpx-consortium/)
> [Validation of a Cardiopulmonary Exercise Test Score in Heart Failure](https://www.ahajournals.org/doi/pdf/10.1161/circheartfailure.112.000073)
> [Tools for timing in heart failure: what–when–how?—the prognostic value ...](https://academic.oup.com/eurjpc/article/31/11/1430/7257452)
> [Cardiopulmonary Exercise Testing and Prognosis in Chronic Heart Failure*](https://journal.chestnet.org/article/S0012-3692%2815%2931240-X/fulltext)
> [MECKI Score - Cardiologico Monzino](https://www.cardiologicomonzino.it/en/mecki-score/)
> [Cardiopulmonary Exercise Testing in the Prognostic Assessment of Heart ...](https://www.mdpi.com/1648-9144/61/10/1770)
> [International validation of the Metabolic Exercise test data combined ...](https://www.x-mol.com/paper/1667205566742380544)
> [Cardiopulmonary Exercise Testing: Adjunctive and Practical Applications](https://professional.heart.org/en/science-news/2016-focused-update-clinical-recommendations-for-cardiopulmonary-exercise-testing-data-assessment/Commentary)
> [Prognostic Power of the Metabolic Exercise Test Data Combined with ...](https://www.jhltonline.org/article/S1053-2498%2825%2901421-4/fulltext)
> [Oxygen Uptake Efficiency Slope and Prognosis in Heart Failure With ...](https://www.ajconline.org/article/S0002-9149%2823%2900390-9/fulltext)
>
> **Looking into clustering, phenotyping, and CPET literature**
>
> I might search for some literature on unsupervised clustering and phenotyping caution, but it might not be necessary if reasoning is strong enough. If clustering is seen as phenotyping rather than risk labels, I could reference prediction modeling or CPET studies. I could also mention the 2025 China CPET cohort and its relevance as a future platform for external validation. Additionally, I could explore thresholds for exercise prescription via VT1/VT2 if we need more direct evidence.
>
> **Clarifying citations and methodology for CPET**
>
> I might need citations for Chinese expert consensus on standardized CPET application in 2022. Also, one more search could confirm the CPET score weights—some scores use unequal weights, but I found sources listing explicit weights. Phrase Stage I as a methodology prototype, not a predictive tool. Finally, to support statistical reasoning, I may need citations for why mixed models shouldn't be used unless specific conditions apply.
>
> **Searching for CPET citations and analysis methods**
>
> [ERS technical standard – Reference values for cardiopulmonary exercise ...](https://publications.ersnet.org/content/erj/early/2026/02/26/1399300302463-2025)
> [Reference values for cardiopulmonary exercise testing in healthy adults ...](https://www.timtakken.nl/wp-content/uploads/2016/01/Paap-2014-ERK-CPET-ref-values.pdf)
> [Reference Standards for Cardiorespiratory Fitness by Cardiovascular ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC8751972/)
> [Reference values for arm ergometry cardiopulmonary exercise testing ...](https://bmjopenrespres.bmj.com/content/12/1/e002806)
> [Updated Reference Standards for Cardiorespiratory Fitness Measured with ...](https://www.mayoclinicproceedings.org/article/S0025-6196%2821%2900645-5/fulltext)
> [Reference values for cardiopulmonary exercise testing in healthy ...](https://www.tandfonline.com/doi/pdf/10.1080/14779072.2019.1627874)
> [Recent advances in lung function standard value prediction equations ...](https://www.sciencedirect.com/science/article/pii/S2212534525001467)
> [Normative Peak Cardiopulmonary Exercise Test Responses in Canadian ...](https://journal.chestnet.org/article/S0012-3692%2820%2931886-9/fulltext)
> [Reference values for arm ergometry cardiopulmonary exercise testing ...](https://www.ivysci.com/en/articles/9940812__Reference_values_for_arm_ergometry_cardiopulmonary_exercise_testing_CPET_in_healthy_volunteers)
> [Reference values for cardiopulmonary exercise testing in healthy ...](https://pubmed.ncbi.nlm.nih.gov/31161825/)
> [Reference values for cardiopulmonary exercise testing-derived ...](https://link.springer.com/article/10.1007/s00421-025-05978-w)
> [Updated Reference Standards for Cardiorespiratory Fitness Measured with ...](https://search.lib.asu.edu/discovery/fulldisplay/cdi_proquest_miscellaneous_2601484760/01ASU_INST%3A01ASU)
> [Reference values for cardiopulmonary exercise testing in healthy ...](https://research.rug.nl/en/publications/reference-values-for-cardiopulmonary-exercise-testing-in-healthy--2)
> [Reference values for cardiopulmonary exercise testing in healthy ...](https://cris.maastrichtuniversity.nl/en/publications/reference-values-for-cardiopulmonary-exercise-testing-in-healthy-/)
> [Reference values for cardiopulmonary exercise testing-derived ...](https://bartbongers.com/wp-content/uploads/Houtkamp-et-al.-2025-reference-values-CRF-CPET-older-adults.pdf)
>
> **Reviewing data sources and aligning F1 score details**
>
> I could use the GLI GAMLSS method as an alternative. A search for Weber classification or HF risk scoring might not be necessary since CPX score and MECKI are reliable. I also need to check the design details for Stage I and confirm the F1 score in the P1 ablation, potentially citing supplementary materials.
>
> **Searching for GLI GAMLSS and supplementary citations**
>
> [cpet-safety-line-stage1/paper/supplementary.tex at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/supplementary.tex)
>
> **Considering citation for bootstrap CI and deviation**
>
> I need to find a citation for bootstrap confidence intervals (CI) and any literature that discusses the +21% deviation. This could help clarify any potential sources or explanations for the observed variation. I'll search for relevant studies to back this up.
>
> **Searching for bootstrap CI and literature deviation citations**
>
> [cpet-safety-line-stage1/paper/main_cn.tex at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/main_cn.tex)
>
> **Considering citations for ML features**
>
> I’m thinking of mentioning the core ML outcome features, though I’m not sure if citations are needed. Maybe I should focus on the top features instead. I’ll check for any relevant references on this, just to cover my bases and clarify where these features are discussed.
>
> **Searching for citations on core ML features**
>
> [cpet-safety-line-stage1/paper/supplementary.tex at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/supplementary.tex)
>
> **Considering equal weight design citation**
>
> I think I might want to open or cite the paper’s section related to the equal weight design, especially the lines around "等权." I’ll search for references to it and check whether it's relevant to mention or cite specifically in this context. It could help clarify the design approach.
>
> **Searching for references to equal weight design**
>
> [cpet-safety-line-stage1/paper/main_cn.tex at main · mrxachen/cpet-safety-line-stage1 · GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/main_cn.tex)
>
> **Clarifying equal weight precedent and alternative models**
>
> I’m thinking about mentioning that I couldn’t find a standard CPET safety framework that uses equal top-level weights across three axes, since most have unequal weights (like CPX and MECKI). This could be based on my search results. I might also clarify “Webber-Janicki” as a functional class, not a safety score, although it might not need to be cited.
>
> **Clarifying group definitions and reference-normal subsets**
>
> I’ll need citations for stage I data size and the four groups mentioned in planning. I should also clarify that the control group isn’t necessarily a healthy normative group; I may mention a reference-normal subset if needed. I also want to address the clinician judgment in `test_result` and note that `test_result` is not deterministic
>
> **Verifying details about leakage guard and BP>220 in P1 label**
>
> I’m considering checking for OpenAI usage, although that might not be relevant. I’ll explore the repository’s CLAUDE.md for leakage guard principles, though it might not add much beyond the code. Also, I’ll need to confirm if P1 labels really exclude peak SBP >220, as the user’s prompt omitted it.
>
> **Investigating documentation and code mismatch for peak SBP**
>
> In label_rules_v2, the P1 red criteria list includes only VO2<50, VE/VCO2>36, and EIH=true. However, supplementary line 1015 mentions peak SBP >220, which contradicts the rule. This inconsistency could be important methodologically, and I might need to mention it, provided I can support it with citations from
>
> **Clarifying inconsistencies and seeking literature**
>
> I’m reviewing critical lines, including 851view2 and line 1013 in the documentation, especially around the VE/VCO2 slope threshold. There seems to be some inconsistency in the methods that I should capture. I need to search for literature on composite prognostic scores with AUC >0.70, as the user may be asking about CPET metrics.
>
> **Searching literature on CPET summary metrics and AUC**
>
> [Prognostic value of Cardiopulmonary Exercise Testing in Heart Failure ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC4804356/)
> [Cardiopulmonary Exercise Testing in Heart Failure](https://www.jaegerrdx.com/sites/default/files/2025-11/JAE-GBL-2500045-Cardiopulmonary%20Exercise%20Testing%20in%20Heart%20Failure-CSS_EN_.pdf)
> [Cardiopulmonary Exercise Testing in Advanced Heart Failure Management](https://www.heartfailure.theclinics.com/article/S1551-7136%2824%2900076-X/fulltext)
> [Cardiopulmonary Exercise Testing in Heart Failure☆](https://www.sciencedirect.com/science/article/pii/S0146280615000109)
> [Peak VO2 and VE/VCO2 exhibit differential prognostic capacity for ...](https://academic.oup.com/eurheartj/article/44/Supplement_2/ehad655.931/7392934)
> [Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure ...](https://www.ahajournals.org/doi/pdf/10.1161/jaha.117.006000?download=true)
> [Cardiopulmonary Exercise Testing in the Prognostic Assessment of Heart ...](https://www.mdpi.com/1648-9144/61/10/1770)
> [A meta-analysis of the prognostic significance of cardiopulmonary ...](https://link.springer.com/article/10.1007/s10741-012-9332-0)
> [Understanding the Basics of Cardiopulmonary Exercise Testing](https://www.mayoclinicproceedings.org/article/S0025-6196%2811%2960946-4/fulltext)
> [How to perform and report a cardiopulmonary exercise test in patients ...](https://www.internationaljournalofcardiology.com/article/S0167-5273%2819%2931365-8/fulltext)
> [Oxygen Uptake Efficiency Slope and Prognosis in Heart Failure With ...](https://www.ajconline.org/article/S0002-9149%2823%2900390-9/fulltext)
> [Comprehensive Analysis of Cardiopulmonary Exercise Testing and ...](https://www.academia.edu/23572723/Comprehensive_Analysis_of_Cardiopulmonary_Exercise_Testing_and_Mortality_in_Patients_With_Systolic_Heart_Failure_The_Henry_Ford_Hospital_Cardiopulmonary_Exercise_Testing_FIT_CPX_Project)
> [How to perform and report a cardiopulmonary exercise test in patients ...](https://cpxinternational.com/pubs/how-to-perform-and-report-a-cardiopulmonary-exercise-test-in-patients-with-chronic-heart-failure-2/)
> [Cardiopulmonary exercise testing: A contemporary and versatile clinical ...](https://www.ccjm.org/content/ccjom/84/2/161.full.pdf)
> [Cardiopulmonary Exercise Testing and Prognosis in Chronic Heart Failure*](https://journal.chestnet.org/article/S0012-3692%2815%2931240-X/fulltext)
> [Cardiopulmonary exercise test](https://en.wikipedia.org/wiki/Cardiopulmonary_exercise_test)
>
> **Searching for CPET AUC literature and related metrics**
>
> I need to search for CPET summary metrics in CHD or HF, specifically looking at AUC > 0.70. Even if AUC isn’t explicitly available, I can still cite relevant literature like the CPX score and MECKI, highlighting their prognostic performance. I’ll focus on mortality rates and scoring systems instead.
>
> **Searching literature on CPET scores and AUC**
>
> [Validation of a Cardiopulmonary Exercise Test Score in Heart Failure](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233377/)
> [International validation of the Metabolic Exercise test data combined ...](https://cpxinternational.com/pubs/international-validation-of-the-metabolic-exercise-test-data-combined-with-cardiac-and-kidney-indexes-mecki-score-in-heart-failure/)
> [Oxygen Uptake Efficiency Slope and Prognosis in Heart Failure With ...](https://www.sciencedirect.com/science/article/pii/S0002914923003909)
> [Validation of a Cardiopulmonary Exercise Test Score in Heart Failure](https://www.ahajournals.org/doi/pdf/10.1161/circheartfailure.112.000073)
> [International validation of the Metabolic Exercise test data combined ...](https://academic.oup.com/eurjpc/article/30/13/1371/7191930)
> [Cardiopulmonary Exercise Testing in the Prognostic Assessment of Heart ...](https://www.mdpi.com/1648-9144/61/10/1770)
> [Validation of a cardiopulmonary exercise test score in heart failure ...](https://europepmc.org/article/MED/23392791)
> [International Validation of Metabolic Exercise test data combined with ...](https://www.cardiologicomonzino.it/en/scientific-papers/2023/07/24/international-validation-of-metabolic-exercise-test-data-combined-with/3095/)
> [Cardiopulmonary Exercise Testing in Patients with Chronic Heart Failure ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC2908890/)
> [Validation of a Cardiopulmonary Exercise Test Score in Heart Failure](https://www.sciencegate.app/document/10.1161/circheartfailure.112.000073)
> [Cardiopulmonary Exercise and Respiratory Function Testing and Their ...](https://www.scirp.org/journal/paperinformation?paperid=146139)
> [Validation of a cardiopulmonary exercise test score in heart failure ...](https://read.qxmd.com/read/23392791/validation-of-a-cardiopulmonary-exercise-test-score-in-heart-failure)
> [Metabolic exercise test data combined with cardiac and kidney indexes ...](https://www.iris.sssup.it/retrieve/handle/11382/363025/12943/mecki%201_IJC.pdf)
> [Cardiopulmonary Exercise Testing in Advanced Heart Failure Management](https://www.heartfailure.theclinics.com/article/S1551-7136%2824%2900076-X/fulltext)
> [Validation of a cardiopulmonary exercise test score in heart failure](https://pubmed.ncbi.nlm.nih.gov/23392791/)
> [International Validation of Metabolic Exercise test data combined with ...](https://www.lifescience.net/publications/343377/international-validation-of-metabolic-exercise-tes/)
> [Validation of a Cardiopulmonary Exercise Test Score in Heart Failure](https://scispace.com/papers/validation-of-a-cardiopulmonary-exercise-test-score-in-heart-3navsoms64)
> [Oxygen Uptake Efficiency Slope and Prognosis in Heart Failure With ...](https://www.ajconline.org/article/S0002-9149%2823%2900390-9/fulltext)
> [Validation of a Cardiopulmonary Exercise Test Score in Heart Failure](https://scite.ai/reports/validation-of-a-cardiopulmonary-exercise-W1RN5d)
> [International Validation of Metabolic Exercise test data combined with ...](https://iris.unisr.it/handle/20.500.11768/193048)
> [(1329) - Prognostic Significance of Cardiopulmonary Exercise Testing in ...](https://www.jhltonline.org/article/S1053-2498%2825%2901425-1/fulltext)
> [Additive prognostic value of a cardiopulmonary exercise test score in ...](https://www.internationaljournalofcardiology.com/article/S0167-5273%2814%2901953-6/fulltext)
> [International Validation of Metabolic Exercise test data combined with ...](https://air.unimi.it/handle/2434/977733)
> [Submaximal exercise metrics: Looking prior to VO₂max | Heart Failure ...](https://link.springer.com/article/10.1007/s10741-026-10606-6)
> [Validation of a Cardiopulmonary Exercise Test Score in](https://exaly.com/paper-pdf/56362291/citation-report.pdf)
> [International validation of the Metabolic Exercise test data combined ...](https://www.academia.edu/145185917/International_validation_of_the_Metabolic_Exercise_test_data_combined_with_Cardiac_and_Kidney_Indexes_MECKI_score_in_heart_failure)
> [How to Read CPET Results: Oxygen, Heart & Lung Data Explained ...](https://gwinnettlung.com/how-to-interpret-cardiopulmonary-exercise-testing-cpet-results/)
>
> **Clarifying data sets and code inconsistencies**
>
> I’ll mention the potential mismatch in P1 code and paper, particularly around peak SBP > 220 and its exclusion in label_rules_v2. I can also confirm that Stage I data refers to elderly CVD patients, and not healthy individuals, based on the study readme. I don’t need to dig deeper into the code for this.
>
> **Focusing on analysis and citations**
>
> I don’t see a need for any special skills, like creating PDFs or spreadsheets, for this task. While the user didn’t explicitly ask for a document format, I need to
>
> **Final outline and wording considerations**
>
> I’ll structure the final response with headings for clarity: 
> 1. General Conclusions  
> 2. Conclusions on five key issues  
> 3. Specific recommendations for the five dimensions  
> 4. Actionable Stage I restructuring path  
> 5. Recommended literature  
> 
> I’ll also mention which files I reviewed and avoid overstating conclusions regarding the absence of prior literature, referencing CPX/MECKI instead as a contrast without over-asserting certainty.
>
> **Clarifying the framework and inconsistencies**
>
> I can say that the system isn't “equal weight axes,” but rather a combination of “equal top layer + heuristic inner layer + additional bonuses/penalties.” This insight is based on the code. Additionally, there is a structural circularity with P1, as the deterministic label uses the same variables that leakage_guard excludes. I'll mention the F1 inconsistencies detailed in the paper.
>
> **Addressing clinical alignment and reference discrepancies**
>
> The negative correlation with Mahalanobis D² and reversed gradient suggests misalignment between reference-distance and clinical risk. There's also uncertainty in concordance (73.5%) and high-confidence (26.2%), indicating a lack of consensus. These failures suggest that current summary-level features don’t converge to a single "safety" construct.
>
> **Proposing Stage I pipeline and validation considerations**
>
> To refine Stage I, I’m proposing a 7-step pipeline: 1) Abandon P1 supervised classification. 2) Define primary estimand. 3) Reduce variable set. 4) Use EFA/PCA for dimensionality. 5) Build latent scores with Bayesian regression/SEM. 6) Derive zones via centiles or calibration. 7) Focus on construct validation, with internal validation methods like cross-validation and bootstrapping, avoiding split samples where possible unless supported by sources.
>
> **Searching clinical prediction model validation recommendations**
>
> [Evaluation of clinical prediction models (part 1): from ... - The BMJ](https://www.bmj.com/content/384/bmj-2023-074819)
> [Evaluation of clinical prediction models (part 1): from development to ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC10772854/)
> [Validation in prediction research: the waste by data splitting](https://www.sciencedirect.com/science/article/pii/S0895435618304852)
> [Validation in prediction research: the waste by data splitting](https://www.jclinepi.com/article/S0895-4356%2818%2930485-2/fulltext)
> [Internal Validation of Clinical Prediction Models • pminternal](https://stephenrho.github.io/pminternal/)
> [Clinical prediction models in psychiatry: a systematic review of two ...](https://www.nature.com/articles/s41380-022-01528-4)
> [External validation of prognostic models: what, why, how, when and ...](https://academic.oup.com/ckj/article/14/1/49/6000246)
> [Developing clinical prediction models: a step-by-step guide | The BMJ](https://www-bmj-com.bibliotheek.ehb.be/content/386/bmj-2023-078276)
> [Implementation and Updating of Clinical Prediction Models: A Systematic ...](https://www.mcpdigitalhealth.org/article/S2949-7612%2825%2900035-5/fulltext)
> [www.clinicalpredictionmodels.org - Chapter 17](https://www.clinicalpredictionmodels.org/extra-material/chapter-17)
> [A comparison of hyperparameter tuning procedures for clinical ...](https://onlinelibrary.wiley.com/doi/epdf/10.1002/sim.9932)
> [A guide to systematic review and meta-analysis of prediction model ...](https://methods.cochrane.org/sites/methods.cochrane.org.prognosis/files/uploads/2017_debray_et_al_bmj_a_guide_to_sr_and_ma_of_prediction_models.pdf)
> [Methodological guidance for the evaluation and updating of clinical ...](https://link.springer.com/content/pdf/10.1186/s12874-022-01801-8.pdf)
> [Prediction Model Validation: Internal vs External, Bootstrapping, and ...](https://www.uniqcret.com/post/prediction-model-validation)
> [Validation of prognostic models: challenges and opportunities ...](https://jeccm.amegroups.org/article/view/4742/5275)
> [Stability of clinical prediction models developed using statistical or machine learning methods](https://arxiv.org/abs/2211.01061)
>
> **Addressing sample size and validation strategy**
>
> For machine learning, a sample size between 500-1500 is ideal. However, with N 3200, overfitting remains possible since only 14.7% are positive events. I'd suggest using internal validation via cross-validation or bootstrap over the 80/20 split mentioned in the paper, especially with limited positives.
>
> **Structuring deep feedback while balancing length**
>
> The strongest result here isn’t predictive performance but the empirical falsification of CPET labels. I wonder if the final feedback might be too long, but the user wants detailed input, so I'll aim for 2300-3000 Chinese characters. I'll structure it with headings, paragraphs
>
> **Evaluating CPET safety stratification prototype**
>
> At this stage, I consider the CPET-safety-line-stage1 to be a more credible "summary-level methodology prototype" rather than a deployable predictor. I should make sure to differentiate it clearly, emphasizing its role in safety stratification rather than making broader predictions.
>
> **Highlighting limitations and recommendations for Stage I**
>
> Since Stage I planning prioritizes safety over predictive accuracy, and the empirical results show ML doesn't outperform the 2-variable baseline (AUC 0.548), the model design faces some limitations. The Mahalanobis approach isn't well-aligned, and concordance is uncertain. I recommend redesigning labels and considering a supervised endpoint only with test results if follow-up isn't available. Also, note the potential issue of reproducibility mismatch due to inconsistent methods.
>
> **Ventilatory thresholds and reference equations**
>
> Ventilatory thresholds are often used for exercise intensity prescription, but they shouldn't be mistaken for safety zones. For the model redesign, we can reduce to 2 domains if there's overlap, or use weighted models like penalized ordinal regression. Also, I'd suggest recalibrating local models against external Chinese reference equations.
>
> **Stage I pathway and recommendations**
>
> For Stage I, I’ll label it as a methodology framework prototype, focused on construct validation, not prediction. The proposed 6-step pipeline includes assessing safety phenotypes, feature selection, dimensionality testing, building continuous latent scores, defining descriptive zones, and using internal resampling validation for reporting. K-means/GMM would be reserved for phenotype discovery only.
>
> **Structuring the report and citations**
>
> The expert consensus for 2026 emphasizes risk assessment and prevention in exercise therapy, which I’ll already cite. To ensure coverage: I’ll reference the uploaded prompt in the intro or closing, and include citations at the end of each paragraph. For actionable recommendations, I’ll incorporate references, ensuring the facts come from reliable sources, without overloading on bullet points. Bold subheadings and concise paragraphs will help. Let's move forward with the outline.
>
> **Finalizing citations and conclusion points**
>
> I’ll ensure citations cover the range of equations, studies, and methodologies used, like the Chinese references, GAMLSS, and TRIPOD+AI validations. For the conclusion, I’ll mention threshold recalibration (+21% deviation, 39.5% reclassification) as a key positive result. If the `filecite` and web citations are covered, adding an image carousel or tables might not be necessary. Keeping citations right is key though.
>
> **Emphasizing calibration and referencing key findings**
>
> Stage I should highlight the local-threshold calibration as a significant innovation, especially with the +21% shift and 39.5% reclassification. It's essential to mention the control group's mismatch with a healthy normative group, and reference the 2022 Chinese expert consensus on standardized CPET. There’s also value in noting the paper-code mismatch after reviewing both.
>
> **Clarifying task definitions and model recommendations**
>
> Section 1 emphasizes P1 being a task definition issue rather than a feature engineering one, citing the deterministic zones based on specific metrics like vo2_peak_pct_pred and ve_vco2_slope. In Section 2, I suggest using test_result for Stage I labels, not including follow-up, and clarifying the peak SBP mismatch between P1 supplementary and label_rules_v2.
>
> **Addressing reference equations and local comparators**
>
> For Section 3, I point out that an R² of 0.392 works for group-level normalization but weak for personal thresholds. I suggest benchmarking against Chinese references using GAMLSS or quantile regression for cutoff points. Also, calling the local reference subset a "lab-local comparator" feels more accurate. Moving to Phase G, three methods converge on the same message: outcome-anchored AUC of 0.548 indicates test_result noise, not CPET uselessness.
>
> **Final thoughts on evaluation, validation, and literature**
>
> For assessment, I’d suggest deriving a continuous score and creating zones based on descriptive centiles or mixture boundaries. It’s also important to validate the construct using gradients in test results, disease groups, and adverse patterns, alongside s decision curves and calibration. When using K-means/GMM, only explore phenotype discovery—not safety colors—until external anchoring. For literature, I’d recommend referencing aspects like Chinese norms, clinical prognosis, multidimensional CPET scoring, and key methodology guides. Don’t forget to cite TRIPOD+AI and PROBAST+AI where needed!
>
> **Framing the methodology paper**
>
> I think it’s important to frame the work as a methodology paper, not focusing on prediction. It might be better suited for journals focused on methods, rehabilitation, CPET, or the Chinese population. I could suggest using a more appropriate title like "A Methodology for Constructing Summary-Level CPET Laboratory Safety Phenotypes in Older Cardiovascular Patients." The
>
> **Refining Stage II strategy and addressing uncertainties**
>
> Stage II should focus on raw breath-by-breath data to refine dynamic features and resolve ambiguities—the current approach hits a summary-level ceiling. Key focus could be addressing the uncertain 73.5% with features like O2 pulse kinetics and HR/BP kinetics. Also, mention the supplementary vs. code mismatch issue and the control group difference. Tie this to planning Stage II for greater predictive accuracy.
>
> **Ensuring authoritative citations and addressing literature challenges**
>
> I need to make sure that more than half of the citations come from reputable sources, like PubMed, BMJ, and recognized Chinese journals. Also, while search result snippets are fine, I'll aim for citations from original articles. Acknowledging potential caveats in literature like MECKI/CPX specificities for mixed cohorts is also important.
>
> **Clarifying AUC and CPX score considerations**
>
> We can cite literature showing AUC>0.70, supporting our recommendations. MECKI’s AUC values at different time points are good for AUC>0.70, but note that MECKI includes multiple indices, not just CPET. It's fine if CPX score doesn’t have AUC>0.70, but we can still mention it.
>
> **Proposing final paper phrasing**
>
> I’m thinking about how to phrase our work: 
> 
> "We suggest a summary-level CPET laboratory safety phenotype, not a fully-developed prognostic classifier.” Also, "While summary-level CPET aids in robust local threshold calibration, it doesn't fully clarify individual safety labels, especially when these labels are defined from the same CPET
>
> **Clarifying score and exercise habit considerations**
>
> It's fine for a descriptive score, but it does complicate things since part of it reflects an EIH response, not a pure safety construct. The T-axis adds an exercise habit variable based on self-report, which could blur its original construct. If Stage I focuses solely on CPET, we may want to reconsider this mix.
>
> **Exploring external comparators and clustering**
>
> The search result mentions normative standards by cardiovascular disease category for treadmill or cycle tests, which could be useful as an external comparator, even if unnecessary. I also see that the FRIEND database has disease-specific CP
>
> **Organizing the report structure in Chinese translation**
>
> To maintain clarity, I'll use a professional, direct Chinese translation style with moderate headers:
> - 总判断 (Overall Judgment)
> - 根本问题 (Fundamental Issues)
> - 我建议的 Stage I 路线 (My Suggested Stage I Approach)
> - 文献建议 (Literature Suggestions)
> 
> I'll also use simple bullet lists to keep it organized and concise. The report will have numbered sections to reflect the requested output.
>
> Thought for 26m 26s

我按你上传的咨询框架，系统读了仓库的 `PLANNING.md`、`DEVLOG.md`、`CLAUDE.md`、主文/补充材料、`label_rules_v2/v3.yaml`、`leakage_guard.py` 和 `zone_engine_v2.py`，再对照近年的中国与国际 CPET 文献来判断。我的总结论是：这个项目已经很清楚地证明了 Stage I 的价值边界，但它目前应被定义为\*\*“汇总级 CPET 的方法学原型”**，而不是一个已经可部署的“安全预测工具”。根本瓶颈不是模型还不够强，而是**安全构念、监督标签、实现路径之间仍有混杂和漂移\*\*。

chatgpt\_consultation\_prompt

[BMJ+4GitHub+4GitHub+4](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/docs/PLANNING.md)

先说我认为最核心的一句判断：你们现在把“安全”同时定义成了三件不同的事。`PLANNING.md` 里，Stage I 的安全区原本是要锚定 `test_result` 的“状态→结局”映射；`label_rules_v2.yaml` 里的 P1 又是由 VO₂peak%pred、VE/VCO₂ slope、EIH 直接确定性定义出来的规则标签；而论文和 `zone_engine_v2.py` 主线最终采用的却是**相对于 reference-normal subset 的分位偏离**来切 P75/P90。也就是说，仓库里“安全”同时在指“临床结局代理”“规则型异常”“相对正常偏离”三种构念，它们当然不会天然一致，这正是后面 outcome-anchor AUC 低、Mahalanobis 与结局几乎无关、四定义一致性只有 26.2% 高信度的上游原因。[GitHub+5GitHub+5GitHub+5](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/docs/PLANNING.md)

还有一个我会优先修的“发表级”问题：**版本漂移**。`zone_engine_v2.py` 顶部文档还写着“数据驱动权重 + Youden cutpoints”，但实际代码已经固定为 R/T/I 等权，并以 reference percentile 作为主切点，Youden 只保留为验证；补充材料把“峰值 SBP >220 mmHg”写成 P1 条件，但当前 `label_rules_v2.yaml` 的 P1 区规则并没有这个项。这类文档—代码—论文的不一致，会直接伤害可复现性，也会让审稿人怀疑不同结果是否来自同一方法版本。[GitHub+4GitHub+4GitHub+4](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/src/cpet_stage1/labels/zone_engine_v2.py)

1) 对 R/T/I 三轴等权框架的根本性评价
-----------------------

我没有在主流 CPET 风险分层文献里找到与当前设计同构、且已经过外部验证的“Reserve / Threshold / Instability 三轴等权交通灯”框架。临床上更成熟的有两条线：一条是**处方分区**，即围绕 VT1/VT2 定义运动强度域；另一条是**预后分层**，即结合 peak VO₂、VE/VCO₂ slope、OUES、HRR 等做 Weber/ventilatory functional class、CPX score、MECKI 之类的复合评分。换句话说，R/T/I 的“分轴思路”是有启发性的，但“等权交通灯”本身更像你们的原创原型，而不是现成共识。[PubMed+6Yiigle+6PMC+6](https://rs.yiigle.com/cmaid/1430505)

这个等权设计的最大风险，不是“权重可能偏了 10%”，而是它把**不同语义层次**的变量放进了同一个算术平均。R 轴和 T 轴更多反映的是能力与效率，I 轴更像测试中的**不稳定/警报条件**。把 EIH 或极端血压反应平均进总分，容易产生两类错判：一类是生理能力还不错、但存在危险反应的患者被均值稀释；另一类是慢性低适能、却未出现即时危险信号的患者被过度染红。你们主文里明确把 I 轴写成“峰值 SBP + O₂ 脉搏轨迹 + EIH 惩罚”，再把三轴按 1/3 合成 `S_lab`；这在“避免依赖外部结局”上成立，但并没有证明三轴在构念上是同质、可等权相加的。[GitHub+2GitHub+2](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/main_cn.tex)

如果由我重设计，我会把它改成**分层式而非等权式**：先用 Reserve + Ventilatory 两个连续维度构建“基础表型”，再把 Instability 当作**门控/覆盖规则**，而不是第三个同权轴。更成熟的模板不是 PCA，而是 CPX score、Weber+ventilatory class、MECKI 这类“少量核心指标 + 明确临床语义 + 外部预后验证”的复合路径。PCA 可以做探索性降维，但不适合直接定义安全，因为它最大化的是方差，不是风险。[PubMed+3NCBI+3PMC+3](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233377/)

2) 对标签定义策略的判断与改进
----------------

P1 的循环依赖，在我看来是**结构性标签缺陷**，不是特征工程还不够好。补充材料已经明确写到：传统 P1 由 `{VO₂peak%pred, VE/VCO₂ slope, EIH}` 确定性定义；`leakage_guard.py` 也因此把这些字段强制排除；结果就是泄漏版 F1=0.84，而清洁版只剩 F1=0.47。这个现象的含义非常直接：模型学到的主要不是“安全性”，而是“谁更接近标签规则的阈值”。[GitHub+2GitHub+2](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/supplementary.tex)

所以，对你提出的那个核心问题，我的答案是：**这主要是“标签定义即结局”的循环依赖，不能靠更复杂的特征工程根治。**`label_rules_v3.yaml` 把 EIH 从 P1 里移除，确实去掉了最严重的 100% Red 映射，但只要标签仍由少数导出字段阈值决定，监督模型的“可学习性”就仍然依赖代理变量和噪声，而不是临床上可推广的风险模式。P1 更适合降级为**规则型审计标签**或 **negative control**，而不适合继续充当主监督终点。[GitHub+1](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/configs/data/label_rules_v3.yaml)

在没有随访结局的 Stage I，我认为最可接受的方案不是再造一个三分类“真标签”，而是把输出拆成三层：第一层给**连续生理偏离分数**，第二层给**hard-stop / instability flags**，第三层给**置信度或不确定性**。如果一定要离散化，最稳妥的是“高信度 Green / 高信度 Red / 其余归入 Yellow-Gray”，因为你们自己的 concordance 结果显示高信度只占 26.2%，Green/Red 冲突高达 61.6%。在安全问题里，承认“不确定”往往比强行三分更临床可信。[GitHub+1](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/supplementary.tex)

我不推荐把 K-means 或 GMM 直接拿来替代安全标签。无监督聚类可以很好地做 **phenogrouping**，但它学到的是统计相似性，不是风险方向；在没有外部结局或专家映射时，把聚类直接命名成 Green/Yellow/Red，等于把“表型”误写成“安全”。更合理的用法是：先聚类发现亚型，再由专家审阅或后续结局来命名。[GitHub](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/supplementary.tex)

3) 替代性安全区构建方法
-------------

从已发表方法看，最值得借鉴的不是“等权三轴交通灯”，而是两类成熟框架。第一类是**运动处方分区**：CPET 是心血管康复中运动强度处方的金标准，优先围绕 VT1/VT2 定义强度域；第二类是**预后评分**：在心衰等场景，peak VO₂ 与 VE/VCO₂ slope 的组合，以及 CPX score、MECKI 等复合模型，已经被反复证明比单一阈值更稳。你们现在把“如何安全运动”“这次测试是否异常”“未来事件风险多高”都压进同一个“安全区”词里，构念负担太重。[PubMed+4PMC+4Frontiers+4](https://pmc.ncbi.nlm.nih.gov/articles/PMC10391816/)

中国患者的 CPET 参考数据，其实已经比项目里引用的欧美公式更适合做 Stage I 外锚点。可以优先看四类资料：X-ET 项目（中国成人 cycle CPX 参考值）；Wang 等 2022 年基于 1114 名社区成年人建立的中国成人 cycle CPET 正常参考区间，直接用了 2nd/98th percentile；2024 年 4199 名健康中国人的 treadmill 参考标准；以及 2025 年北医三院团队基于 9155 名中国成人 cycle CPET 建立的新参考方程。与这些相比，继续把 Wasserman/Koch 作为 Stage I 主参照，证据基础已经偏旧。[Nature+3ScienceDirect+3MDPI+3](https://www.sciencedirect.com/science/article/pii/S0167527321004708)

因此，在“参考方程 + Bootstrap 切点”这条线上，我更推荐你们改成\*\*“中国外部参考 + 内部严格 reference subset 的双锚点校准”**。具体做法上，别再只追 OLS 的平均预测，改用**分位数参考或 GAMLSS / 分位回归\*\*来建年龄、性别、BMI、测试方式相关的参考区间。你们自己的结果说明 BMI 已把 VO₂peak 的 R² 从 0.298 提到 0.392，但 DEVLOG 同时显示药物列、合并症、静息 BP/HR、LVEF 等要么全 0、要么全缺失，这意味着继续在现有汇总变量上追更高 R²，边际收益会很快变小。混合效应模型只有在你们存在重复测量、protocol/operator/center 聚类时才真正有用；如果是一人一次、单中心导出，它不是主要解法。[Nature+4GitHub+4GitHub+4](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/main_cn.tex)

另外，你们自己的规划里就写过“对照组不等于健康规范组”；这句话非常关键。FRIEND 现在既有健康成年人参考标准，也有按心血管疾病类别和测试方式分层的参考标准。Stage I 最好不要只拿内部 CTRL 子集当唯一规范，而应把它视作“院内参考”，再和中国健康参考或 FRIEND 的疾病分层标准做外部 sanity check。[GitHub+2ScienceDirect+2](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/docs/PLANNING.md)

4) 我对 Phase G 三种互补方法的解释
-----------------------

Method 1 的 AUC=0.548，我不会解读成“汇总级 CPET 根本没用”，而会解读成：\*\*当前导出的 summary variables 不足以重建 `test_result` 这个异质标签。\*\*补充材料显示 `test_result` 阳性率 14.7%，top features 是 HRpeak、VE/VCO₂ slope、年龄、OUES、VT1/VO₂peak，而且 Red 区阳性率 25.3% 明显高于 Green 区 5.1%。这说明信号并非没有，而是标签本身混合了医生综合判断、ECG/症状、逐呼吸细节等导出表中没有的信息。[GitHub+1](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/supplementary.tex)

Method 2 的 Mahalanobis D² 与 `test_result` 几乎无关，也不奇怪。Mahalanobis 距离衡量的是“离参考协方差结构有多远”，不是“往哪个风险方向偏”。你们补充材料自己也写到，它捕获的是与参考正常人群的多变量偏离，而不是直接的风险方向。对 Stage I，它更适合作为**QC / outlier / phenotype deviation** 指标，而不是主安全标签。[GitHub+1](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/supplementary.tex)

Method 3 的一致性框架，其实暴露了 Stage I 最重要的真实结果：\*\*当前最应该产品化的不是更复杂的分类器，而是不确定性管理。\*\*73.5% 的不确定、61.6% 的 Green/Red 冲突，说明你们现在最可信的输出形式应当自带 indeterminate zone；与此同时，26.2% 的高信度样本和高信度 Red 28.6% vs Green 5.1% 的事件梯度，也说明 Stage I 完全可以写成“高信度端点可识别、中心区需要更多信息”的实验室原型。[GitHub+1](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/supplementary.tex)

5) 我最推荐的 Stage I 完整方法学路径
------------------------

第一步，先做**方法封版**：在论文补充材料里加一张 version-lock 表，逐项写清“哪一个 commit / YAML / code path 产生了哪一张主表和哪一项结果”，把上面提到的三类漂移先消掉。否则后续再怎么改模型，审稿人也会先卡 reproducibility。[GitHub+4GitHub+4GitHub+4](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/src/cpet_stage1/labels/zone_engine_v2.py)

第二步，把 Stage I 输出改成**三层结构**：`phenotype score`（连续 R/T 主体）、`instability override`（EIH、异常 BP、未来若补到 ECG/症状/终止原因就放这里）、`confidence / uncertainty`。最终对外只给三种颜色，但内部机制要是“Green = 高信度低风险；Red = hard-stop 或高信度高风险；Yellow/Gray = 其余”。这会比强行把所有人都塞进等权三分更安全，也更符合你们现有 concordance 结果。[GitHub+1](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/paper/main_cn.tex)

第三步，参考建模上采用**外部中国参考 + 内部分位校准**。用中国成人 cycle / treadmill 参考值或方程做外锚点，再用你们严格筛选的院内 reference subset 做本地校准；主报告输出应从“预测均值”转向“百分位 / z-score / 参考区间位置”。这比继续把 R² 从 0.392 往上推更符合 Stage I 的数据现实。[GitHub+3MDPI+3PubMed+3](https://www.mdpi.com/2077-0383/11/16/4904)

第四步，机器学习只保留两个角色：一个是**negative control**（证明规则型标签的 learnability ceiling），一个是**proxy-outcome 辅助模型**（例如 `test_result` 的二分类 rule-out / rule-in）。不要再把 ML 三分类写成主角。若论文里涉及预测模型，按 TRIPOD+AI 报告，按 PROBAST+AI 自查偏倚，并补足校准、内部验证、适用性边界；BMJ 的系列文章也明确强调，很多模型之所以不能落地，不是因为 AUC 不够高，而是因为设计、验证和适用性论证不够扎实。[BMJ+3BMJ+3BMJ+3](https://www.bmj.com/content/385/bmj-2023-078378)

第五步，论文定位请明确写成\*\*“方法学框架原型 / internal derivation / laboratory prototype”\*\*，不要写成“临床决策预测工具”。你们自己的规划文件已经把 Stage I 定义为“建立科学有效且临床可解释的状态→结局映射方法学，不追求预测精度”，这实际上就是最好的投稿定位。[GitHub+2BMJ+2](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/docs/PLANNING.md)

6) 文献推荐清单
---------

最值得优先补进参考文献的中国资料，是 2022 年《中国心肺运动试验临床规范应用专家共识》，它把 CPET 的角色明确放在病理生理解释、预后评估、运动处方和安全性规范上；另一个是 Xiangya 的中国临床运动试验安全性研究，50,142 次测试仅 3 次不良事件，总体不良事件率约 0.6/万次，这篇很适合支撑“CPET 本身是安全可规范开展的，但安全分层算法仍需严谨构建”的背景。[Yiigle+2PMC+2](https://rs.yiigle.com/cmaid/1430505)

中国参考值方面，我会优先引用：X-ET 项目；Wang 等 2022 年社区中国成人 cycle CPET 正常参考值（1114 人，2nd/98th percentile）；2024 年 treadmill 中国参考标准（4199 人）；2025 年北医三院的中国成人 cycle VO₂peak 参考方程（9155 人，含 BMI）。这几篇足以把“必须本地化校准”的论证从经验判断，升级成文献支持。[Nature+3ScienceDirect+3MDPI+3](https://www.sciencedirect.com/science/article/pii/S0167527321004708)

复合评分方面，建议系统补入 Weber + ventilatory functional class 的现代验证、CPX score 的独立验证、以及 MECKI 的国际验证。它们共同说明：真正表现稳定、外部可迁移的 CPET 风险模型，通常都不是单一阈值，也不是纯粹无监督聚类，而是**少量核心 CPET 指标与临床信息的复合模型**。[Air+5PMC+5DOAJ+5](https://pmc.ncbi.nlm.nih.gov/articles/PMC8174289/)

如果你想找“汇总指标也能达到 >0.70”的例子，我会提醒你：这类结果多见于**特定疾病场景 + 真实随访结局 + 复合评分**。例如 Hull CPET risk score 在轻中度心衰中 AUC 可到 0.78；MECKI、CPX score 也都是在心衰预后场景里建立起来的。与此相对，单个 summary-level 变量在混合心血管人群里通常很难单独撑起稳定的高 AUC。[Heart+2NCBI+2](https://heart.bmj.com/content/100/10/781)

最后，方法学规范建议把 TRIPOD+AI、PROBAST+AI、以及 BMJ 2024 的 prediction-model evaluation 系列一起补进来。对你们这个项目，它们最有用的不是“格式要求”，而是帮助你们把论文叙事从“我们为什么没把 AUC 做高”转成“我们如何在标签、验证、适用性上把原型说清楚”。[PMC+3BMJ+3BMJ+3](https://www.bmj.com/content/385/bmj-2023-078378)

**一句话收束**：这个项目最应该保留的，不是 P1 三分类模型，而是你们已经逼出来的一个很重要的方法学事实——\*\*在汇总级 CPET、缺乏随访和缺失关键临床字段的条件下，Stage I 的最优产物不是高精度预测器，而是一个“以中国参考值为外锚、以不确定性为显式输出、把表型与 hard-stop 条件分开的实验室原型”。\*\*把这件事写透，论文会比继续追逐 0.70 的 AUC 更强。[Nature+4GitHub+4GitHub+4](https://github.com/mrxachen/cpet-safety-line-stage1/blob/main/docs/PLANNING.md)



---
Powered by [ChatGPT Exporter](https://www.chatgptexporter.com)